![]() ![]() Patients are also ineligible for this program if they are Medicare eligible and enrolled in an employer-sponsored group waiver health plan or government-subsidized prescription drug benefit program for retirees. This may also include state pharmaceutical assistance programs and other federal or state plans not listed. This includes patients enrolled in Medicare Part B, Medicare Part D, Medicaid, Medigap, Veterans Affairs (VA), Department of Defense (DoD) programs or TriCare. *Patients are not eligible for this program if they are covered by any federal or state prescription insurance program. ![]() The assistance provided by the GSK Co-pay Program cannot be combined with any other assistance program, free trial, discount, prescription savings card, or other offer. The value of the GSK Co-Pay Program is exclusively for the benefit of enrolled patients and is intended to be credited toward patient out-of-pocket responsibilities (e.g., copayments, coinsurance, annual deductibles, and annual out-of-pocket maximums). The assistance provided by the GSK Co-pay Program is offered to, and intended for the sole benefit of eligible patients and may not be transferred to or utilized for the benefit of third parties, including, without limitation, third party payers, pharmacy benefit managers, or the agents of either. Final patient eligibility determinations are provided by the GSK Co-pay Program. ![]() Patients must qualify for the Co-pay Program each year that they wish to participate in the Program. Eligibility in the GSK Co-pay Program is assessed annually. The Co-pay Program will evaluate the patient for eligibility and communicate eligibility to the patient and provider. To determine if a patient is eligible for the BENLYSTA or NUCALA (herein "GSK") Co-pay Program, an enrollment from must be completed and submitted to the Co-pay Program.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |